Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon L Smith

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Journal of Psychopharmacology (Oxford, England)|July 28, 2021
Prospects for new drugs to treat binge-eating disorder: Insights from psychopathology and neuropharmacologyDavid J Heal, Sharon L Smith
Journal of Plankton Research|June 9, 2016
Vertical distribution of Eucalanoid copepods within the Costa Rica Dome area of the Eastern Tropical PacificMelanie L Jackson, Sharon L Smith
Journal of Psychopharmacology (Oxford, England)|October 16, 2025
Mind the gap! Addressing unresolved aspects of abuse potential evaluation and scheduling of classic and novel psychedelic drugsDavid J Heal, Jane Gosden, Sharon L Smith
Advances in Pharmacology (San Diego, Calif.)|March 11, 2024
Stimulant prodrugs: A pharmacological and clinical assessment of their role in treating ADHD and binge-eating disorderDavid J Heal, Jane Gosden, Sharon L Smith
Current Topics in Behavioral Neurosciences|May 4, 2022
New Drugs to Treat ADHD: Opportunities and Challenges in Research and DevelopmentDavid J Heal, Jane Gosden, Sharon L Smith
Neuropharmacology|June 24, 2014
Dopamine reuptake transporter (DAT) "inverse agonism"--a novel hypothesis to explain the enigmatic pharmacology of cocaineDavid J Heal, Jane Gosden, Sharon L Smith
Neuropharmacology|February 11, 2018
Evaluating the abuse potential of psychedelic drugs as part of the safety pharmacology assessment for medical use in humansDavid J Heal, Jane Gosden, Sharon L Smith
British Journal of Clinical Pharmacology|December 17, 2009
Regulatory challenges for new drugs to treat obesity and comorbid metabolic disordersDavid J Heal, Jane Gosden, Sharon L Smith
Brain Research|October 18, 2002
Diet-induced obesity increases mu opioid receptor binding in specific regions of the rat brainSharon L Smith, Joanne A Harrold, Gareth Williams
Neuropharmacology|February 9, 2012
What is the prognosis for new centrally-acting anti-obesity drugs?David J Heal, Jane Gosden, Sharon L Smith
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Journal of Psychopharmacology (Oxford, England)|July 28, 2021
Prospects for new drugs to treat binge-eating disorder: Insights from psychopathology and neuropharmacologyDavid J Heal, Sharon L Smith
Journal of Plankton Research|June 9, 2016
Vertical distribution of Eucalanoid copepods within the Costa Rica Dome area of the Eastern Tropical PacificMelanie L Jackson, Sharon L Smith
Journal of Psychopharmacology (Oxford, England)|October 16, 2025
Mind the gap! Addressing unresolved aspects of abuse potential evaluation and scheduling of classic and novel psychedelic drugsDavid J Heal, Jane Gosden, Sharon L Smith
Advances in Pharmacology (San Diego, Calif.)|March 11, 2024
Stimulant prodrugs: A pharmacological and clinical assessment of their role in treating ADHD and binge-eating disorderDavid J Heal, Jane Gosden, Sharon L Smith
Current Topics in Behavioral Neurosciences|May 4, 2022
New Drugs to Treat ADHD: Opportunities and Challenges in Research and DevelopmentDavid J Heal, Jane Gosden, Sharon L Smith
Neuropharmacology|June 24, 2014
Dopamine reuptake transporter (DAT) "inverse agonism"--a novel hypothesis to explain the enigmatic pharmacology of cocaineDavid J Heal, Jane Gosden, Sharon L Smith
Neuropharmacology|February 11, 2018
Evaluating the abuse potential of psychedelic drugs as part of the safety pharmacology assessment for medical use in humansDavid J Heal, Jane Gosden, Sharon L Smith
British Journal of Clinical Pharmacology|December 17, 2009
Regulatory challenges for new drugs to treat obesity and comorbid metabolic disordersDavid J Heal, Jane Gosden, Sharon L Smith
Brain Research|October 18, 2002
Diet-induced obesity increases mu opioid receptor binding in specific regions of the rat brainSharon L Smith, Joanne A Harrold, Gareth Williams
Neuropharmacology|February 9, 2012
What is the prognosis for new centrally-acting anti-obesity drugs?David J Heal, Jane Gosden, Sharon L Smith
Pageof 4